PharmGKB summary: very important pharmacogene information for human leukocyte antigen B
- PMID: 25647431
- PMCID: PMC4356642
- DOI: 10.1097/FPC.0000000000000118
PharmGKB summary: very important pharmacogene information for human leukocyte antigen B
Similar articles
-
PharmGKB summary: very important pharmacogene information for UGT1A1.Pharmacogenet Genomics. 2014 Mar;24(3):177-83. doi: 10.1097/FPC.0000000000000024. Pharmacogenet Genomics. 2014. PMID: 24492252 Free PMC article. Review. No abstract available.
-
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update.Clin Pharmacol Ther. 2016 Jan;99(1):36-7. doi: 10.1002/cpt.161. Epub 2015 Jul 16. Clin Pharmacol Ther. 2016. PMID: 26094938 Free PMC article.
-
Human leukocyte antigen (HLA) and pharmacogenetics: screening for HLA-B*57:01 among human immunodeficiency virus-positive patients from southern Alberta.Hum Immunol. 2012 Feb;73(2):164-7. doi: 10.1016/j.humimm.2011.12.002. Epub 2011 Dec 8. Hum Immunol. 2012. PMID: 22197535
-
HLA-A, -B, and -DRB1 polymorphism defined by sequence-based typing of the Han population in Northern China.Tissue Antigens. 2006 Feb;67(2):146-52. doi: 10.1111/j.1399-0039.2006.00529.x. Tissue Antigens. 2006. PMID: 16441486
-
PharmGKB summary: very important pharmacogene information for RYR1.Pharmacogenet Genomics. 2016 Mar;26(3):138-44. doi: 10.1097/FPC.0000000000000198. Pharmacogenet Genomics. 2016. PMID: 26709912 Free PMC article. Review. No abstract available.
Cited by
-
Translational Pharmacogenomics: Discovery, Evidence Synthesis and Delivery of Race-Conscious Medicine.Clin Pharmacol Ther. 2021 Oct;110(4):909-925. doi: 10.1002/cpt.2357. Epub 2021 Jul 29. Clin Pharmacol Ther. 2021. PMID: 34233023 Free PMC article. Review.
-
Clinical Utility of HLA-B*58:01 Genotyping to Prevent Allopurinol-Induced SJS/TEN.Hosp Pharm. 2021 Dec;56(6):660-663. doi: 10.1177/0018578720934972. Epub 2020 Jun 13. Hosp Pharm. 2021. PMID: 34732918 Free PMC article.
-
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.Eur J Hum Genet. 2019 Mar;27(3):442-454. doi: 10.1038/s41431-018-0300-6. Epub 2018 Nov 12. Eur J Hum Genet. 2019. PMID: 30420678 Free PMC article.
-
A Screening Test for HLA-B∗15:02 in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events.Front Pharmacol. 2019 Mar 26;10:149. doi: 10.3389/fphar.2019.00149. eCollection 2019. Front Pharmacol. 2019. PMID: 30971914 Free PMC article.
-
Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations.Pharm Res. 2018 Sep 17;35(11):211. doi: 10.1007/s11095-018-2472-8. Pharm Res. 2018. PMID: 30225831 Review.
References
-
- Horton R, et al. Gene map of the extended human MHC. Nat Rev Genet. 2004;5(12):889–99. - PubMed
-
- Neefjes J, et al. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol. 2011;11(12):823–36. - PubMed
-
- Janeway CAJT, P., Walport M, Shlomchik MJ. Immunobiology: The Immune System in Health and Disease. Garland Science; New York: 2001.